Nitroglycerin and Lumason drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitroglycerin (nitroglycerin) and Lumason (sulfur hexafluoride lipid-type a microspheres). Common drug interactions include nausea among females and anaphylactic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Nitroglycerin and Lumason. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.

What is Lumason?

Lumason has active ingredients of sulfur hexafluoride lipid-type a microspheres. eHealthMe is studying from 935 Lumason users. Check the latest studies of Lumason.



On Jul, 30, 2026

30 people who take Nitroglycerin and Lumason together, and have interactions are studied.

Nitroglycerin and Lumason drug interactions.

What are the common drug interactions of Nitroglycerin and Lumason, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Anaphylactic reaction (serious allergic reaction)
  3. Acute myocardial infarction (acute heart attack)
  4. Agitation (state of anxiety or nervous excitement)
  5. Cardiac arrest
  6. Cardiogenic shock (inadequate circulation of blood)
  7. Crying
  8. Dizziness
  9. Eye movement disorder
  10. Hypersensitivity

male:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  2. Anaphylactic reaction (serious allergic reaction)
  3. Pruritus (severe itching of the skin)
  4. Heart rate decreased
  5. Feeling hot
  6. Pulseless electrical activity
  7. Unresponsive to stimuli
  8. Dyspnoea (difficult or laboured respiration)
  9. Erythema (redness of the skin)
  10. Heart rate increased

What are the common drug interactions of Nitroglycerin and Lumason, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  2. Blood pressure decreased
  3. Dizziness
  4. Dyspnoea (difficult or laboured respiration)
  5. Erythema (redness of the skin)
  6. Heart rate increased
  7. Hyperhidrosis (abnormally increased sweating)
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

50-59:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  2. Nausea (feeling of having an urge to vomit)
  3. Anaphylactic reaction (serious allergic reaction)
  4. Blood pressure decreased
  5. Cardiac arrest
  6. Hyperhidrosis (abnormally increased sweating)
  7. Burning sensation
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Dizziness
  10. Hypersensitivity

60+:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Nausea (feeling of having an urge to vomit)
  3. Pruritus (severe itching of the skin)
  4. Syncope (loss of consciousness with an inability to maintain postural tone)
  5. Unresponsive to stimuli
  6. Vomiting
  7. Feeling hot
  8. Agitation (state of anxiety or nervous excitement)
  9. Blood pressure decreased
  10. Cold sweat

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 2 people, 6.67%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Nitroglycerin and Lumason?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nitroglycerin and Lumason:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nitroglycerin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lumason:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitroglycerin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lumason and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin and sulfur hexafluoride lipid-type a microspheres (the active ingredients of Nitroglycerin and Lumason, respectively), and Nitroglycerin and Lumason (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: